- Copaxone is either a 2014 or 2015 launch.
- The biosimilar franchise has value and there is a milestone on M923 this year.
- Momenta cash burn will not exceed its resources prior to milestones.
Momenta Pharmaceuticals Inc is a biotechnology company that analyzes, characterizes and designs complex pharmaceutical products. It has complex systems analysis platform to resolve the complexity of molecular structures and related biologic systems.